LICENSE AGREEMENTLicense Agreement • December 30th, 2013 • Signal Genetics LLC • Services-medical laboratories • Arkansas
Contract Type FiledDecember 30th, 2013 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “AGREEMENT”) is made by and between the Board of Trustees of the University of Arkansas acting for and on behalf of the University of Arkansas for Medical Sciences, a public institution of higher education having principal offices at 2404 North University Avenue, Little Rock, Arkansas 72207, United States of America (hereinafter “UNIVERSITY”), and Myeloma Health LLC, a Delaware limited liability company having a principal office at 667 Madison Avenue, 14th Floor, New York, New York 10065 (hereinafter “LICENSEE”), as of the EFFECTIVE DATE (as later defined herein).
AMENDMENT #2 to the LICENSE AGREEMENTLicense Agreement • December 30th, 2013 • Signal Genetics LLC • Services-medical laboratories
Contract Type FiledDecember 30th, 2013 Company IndustryTHIS AMENDMENT (“Amendment”) is made by and between the Board of Trustees of the University of Arkansas acting for and on behalf of the University of Arkansas for Medical Sciences, a public institution of higher education having principal offices at 2404 North University Avenue, Little Rock, Arkansas 72207, United States of America (hereinafter “University”), and Myeloma Health LLC, a Delaware limited liability company having a principal office at 667 Madison Avenue, 14th Floor, New York, New York 10065 (hereinafter “Licensee”).
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • December 30th, 2013 • Signal Genetics LLC • Services-medical laboratories
Contract Type FiledDecember 30th, 2013 Company IndustryTHIS FIRST AMENDMENT (this “AMENDMENT”), made as of September 1, 2010 amends the certain License Agreement, effective as of April 1, 2010 (the “AGREEMENT”), entered into by and between the Board of Trustees of the University of Arkansas acting for and on behalf of the University of Arkansas for Medical Sciences, a public institution of higher education having principal offices at 2404 North University Avenue, Little Rock, Arkansas 72207, United States of America (hereinafter “UNIVERSITY”), and Myeloma Health LLC, a Delaware limited liability company having a principal office at 667 Madison Avenue, 14th Floor, New York, New York 10065 (hereinafter “LICENSEE”), and shall be effective as of the EFFECTIVE DATE (as such term is defined in the AGREEMENT).
AMENDMENT #4 to the LICENSE AGREEMENTLicense Agreement • December 30th, 2013 • Signal Genetics LLC • Services-medical laboratories
Contract Type FiledDecember 30th, 2013 Company IndustryThis Amendment (“Amendment”) is made by and between the Board of Trustees of the University of Arkansas acting for and on behalf of the University of Arkansas for Medical Sciences, a public institution of higher education having principal offices at 2404 North University Avenue, Little Rock, Arkansas 72207 (hereinafter “University”), and Myeloma Health LLC, a Delaware limited liability company having a principal office at 667 Madison Avenue, 14th Floor, New York, New York 10065 (hereinafter “Licensee”).
ASSIGNMENT OF MEMBERSHIP INTERESTSAssignment of Membership Interests • December 30th, 2013 • Signal Genetics LLC • Services-medical laboratories • Delaware
Contract Type FiledDecember 30th, 2013 Company Industry JurisdictionTHIS ASSIGNMENT OF MEMBERSHIP INTERESTS (this “Agreement”) dated as of January 1, 2011, made by and among LEBOW ALPHA LLLP, a Delaware limited liability limited partnership (“LeBow Alpha”), and SIGNAL GENETICS, LLC, a Delaware limited liability company (“Signal”).
AMENDMENT #3 to the LICENSE AGREEMENTLicense Agreement • December 30th, 2013 • Signal Genetics LLC • Services-medical laboratories
Contract Type FiledDecember 30th, 2013 Company IndustryThis Amendment No. 3 (“Amendment No. 3”) is made by and between the Board of Trustees of the University of Arkansas acting for and on behalf of the University of Arkansas for Medical Sciences, a public institution of higher education having principal offices at 2404 North University Avenue, Little Rock, Arkansas 72207 (hereinafter “University”), and Myeloma Health LLC, a Delaware limited liability company having a principal office at 667 Madison Avenue, 14th Floor, New York, New York 10065 (hereinafter “Licensee”).
FIRST AMENDMENT TO AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF SIGNAL GENETICS LLCLimited Liability Company Agreement • December 30th, 2013 • Signal Genetics LLC • Services-medical laboratories • Delaware
Contract Type FiledDecember 30th, 2013 Company Industry Jurisdiction